Imlunestrant. Selective estrogen receptor degrader (SERD), Treatment of breast cancer
DOI:
10.1358/dof.2023.48.1.3476558
Publication Date:
2023-01-18T09:27:24Z
AUTHORS (7)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....